Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactions
- 3 October 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 14 (10) , 1043-1055
Abstract
Introduction: Pharmacomicrobiomics and toxicomicrobiomics study how variations within the human microbiome (the combination of human-associated microbial communities and their genomes) affect drug disposition, action, and toxicity. These emerging fields, interconnecting microbiology, bioinformatics, systems pharmacology, and toxicology, complement pharmacogenomics and toxicogenomics, expanding the scope of precision medicine. Areas covered: This article reviews some of the most recently reported pharmacomicrobiomic and toxicomicrobiomic interactions. Examples include the impact of the human gut microbiota on cardiovascular drugs, natural products, and chemotherapeutic agents, including immune checkpoint inhibitors. Although the gut microbiota has been the most extensively studied, some key drug-microbiome interactions involve vaginal, intratumoral, and environmental bacteria, and are briefly discussed here. Additionally, computational resources, moving the field from cataloging to predicting interactions, are introduced. Expert opinion: The rapid pace of discovery triggered by the Human Microbiome Project is moving pharmacomicrobiomic research from scattered observations to systematic studies focusing on screening microbiome variants against different drug classes. Better representation of all human populations will improve such studies by avoiding sampling bias, and the integration of multiomic studies with designed experiments will allow establishing causation. In the near future, pharmacomicrobiomic testing is expected to be a key step in screening novel drugs and designing precision therapeutics.Keywords
Funding Information
- Cairo University (16-57)
This publication has 114 references indexed in Scilit:
- The protective effect of geniposide on human neuroblastoma cells in the presence of formaldehydeBMC Complementary and Alternative Medicine, 2013
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Use of Ichip for High-Throughput In Situ Cultivation of “Uncultivable” Microbial SpeciesApplied and Environmental Microbiology, 2010
- The NIH Human Microbiome ProjectGenome Research, 2009
- Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolismProceedings of the National Academy of Sciences, 2009
- Symbiotic gut microbes modulate human metabolic phenotypesProceedings of the National Academy of Sciences, 2008
- The Human Microbiome ProjectNature, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Metagenomic Analysis of the Human Distal Gut MicrobiomeScience, 2006
- Initial sequencing and analysis of the human genomeNature, 2001